Toth Financial Advisory Corp Crispr Therapeutics Ag Transaction History

Toth Financial Advisory Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$43.47 - $67.77 $2,173 - $3,388	-50 Reduced 90.91%	5 $0
Q1 2021 Apr 20, 2021	SELL	$110.72 - $210.04 $442 - $840	-4 Reduced 6.78%	55 $7,000
Q2 2020 Jul 14, 2020	BUY	$38.5 - $76.05 $731 - $1,444	19 Added 47.5%	59 $4,000
Q1 2020 Apr 20, 2020	BUY	$33.68 - $62.53 $1,347 - $2,501	40 New	40 $1,000
Q4 2018 Jan 22, 2019	SELL	$22.73 - $42.34 $2,273 - $4,234	-100 Closed	0 $0
Q1 2018 Apr 25, 2018	BUY	$23.52 - $58.17 $2,352 - $5,817	100 New	100 $5,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.